Anita H. Clayton MD
Professor, Psychiatric Medicine, University of Virginia School of Medicine
Join to View Full Profile
2955 Ivy RdCharlottesville, VA 22903
Phone+1 434-243-4646
Fax+1 434-243-4743
Dr. Clayton is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Virginia Medical CenterResidency, Psychiatry, 1985 - 1988- University of Virginia Medical CenterInternship, Transitional Year, 1982 - 1983
University of Virginia School of MedicineClass of 1982
Certifications & Licensure
VA State Medical License 1985 - 2026
IL State Medical License 1983 - 1984
American Board of Psychiatry and Neurology Psychiatry
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2012
Clinical Trials
- Study of Supplementation of Antidepressants With Fish Oil to Improve Time to Clinical Response Start of enrollment: 2009 Sep 01
- Does Vilazodone Help With Antidepressant-associated Sexual Dysfunction? Start of enrollment: 2013 Jan 01
Publications & Presentations
PubMed
- Healthcare resource utilization and costs of using cariprazine as the first versus subsequent adjunctive therapy for major depressive disorder.Prakash S Masand, Anita H Clayton, Mousam Parikh, François Laliberté, Guillaume Germain
Journal of Medical Economics. 2025-12-01 - Novel Pharmacologic Treatments of Female Sexual Dysfunction.Andrew How, Christopher Jowdy, Elli Novatcheva, Anita H Clayton
Clinical Obstetrics and Gynecology. 2025-03-01 - Healthcare resource utilization with adjunctive cariprazine and other atypical antipsychotics in patients with major depressive disorder.Anita H Clayton, Mousam Parikh, Tracy Yee, Daniel Mercer, Haiyan Sun
Current Medical Research and Opinion. 2025-02-01
Press Mentions
Novel Agent Promising for Major Depression: Phase 3 DataJune 13th, 2023- Zuranolone Effective in Major DepressionMay 10th, 2023
- Sage Therapeutics and Biogen Announce Consistent Clinically Meaningful Data for Zuranolone Across the LANDSCAPE and NEST Clinical Development Programs Presented at the European College of Neuropsychopharmacology (ECNP) CongressOctober 4th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
